Cite

HARVARD Citation

    Stirrup, O. et al. (2020). Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation. HIV medicine. 21 (5), pp. 309-321. [Online]. 
  
Back to record